Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Cardlytics Inc (CDLX)

Cardlytics Inc (CDLX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 913,348
  • Shares Outstanding, K 22,828
  • Annual Sales, $ 150,680 K
  • Annual Income, $ -53,040 K
  • 60-Month Beta 1.56
  • Price/Sales 6.06
  • Price/Cash Flow N/A
  • Price/Book 19.62

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate -0.28
  • Number of Estimates 3
  • High Estimate -0.23
  • Low Estimate -0.37
  • Prior Year -0.42
  • Growth Rate Est. (year over year) +33.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
36.09 +10.40%
on 10/14/19
42.19 -5.56%
on 10/31/19
+2.87 (+7.75%)
since 10/11/19
3-Month
30.99 +28.59%
on 08/22/19
42.19 -5.56%
on 10/31/19
+6.94 (+21.11%)
since 08/09/19
52-Week
9.80 +306.58%
on 12/31/18
42.19 -5.56%
on 10/31/19
+20.61 (+107.09%)
since 11/09/18

Most Recent Stories

More News
Will Cardlytics, Inc. (CDLX) Report Negative Earnings Next Week? What You Should Know

Cardlytics, Inc. (CDLX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CDLX : 39.63 (-0.95%)
Cardlytics, Inc. (CDLX) Moves to Buy: Rationale Behind the Upgrade

Cardlytics, Inc. (CDLX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

CDLX : 39.63 (-0.95%)
Cardlytics Announces Pricing of Public Offering of Common Stock

Cardlytics, Inc., (NASDAQ: CDLX), a purchase intelligence platform that helps make marketing more relevant and measurable, today announced the pricing of an underwritten public offering of 2,694,365 shares...

JPM : 129.91 (-0.36%)
WFC : 54.04 (-0.11%)
CDLX : 39.63 (-0.95%)
Cardlytics Announces Proposed Public Offering of Common Stock

Cardlytics, Inc., (NASDAQ: CDLX), a purchase intelligence platform that helps make marketing more relevant and measurable, today announced the launch of a proposed underwritten public offering of 2,694,365...

JPM : 129.91 (-0.36%)
WFC : 54.04 (-0.11%)
CDLX : 39.63 (-0.95%)
Aimia Announces Sale of Half Its Investment in Cardlytics

/NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/

CDLX : 39.63 (-0.95%)
AIM.TO : 3.67 (-0.54%)
Cardlytics, Inc. (CDLX) Reports Q2 Loss, Tops Revenue Estimates

Cardlytics, Inc. (CDLX) delivered earnings and revenue surprises of 47.83% and 11.23%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

CDLX : 39.63 (-0.95%)
Fiserv (FISV) to Post Q2 Earnings: What's in the Offing?

Fiserv's (FISV) second-quarter 2019 results to reflect revenue growth and better operating performance.

SPGI : 255.38 (+0.03%)
FISV : 110.10 (-0.46%)
IQV : 140.03 (+1.77%)
CDLX : 39.63 (-0.95%)
Here's Why Momentum Investors Will Love Cardlytics, Inc. (CDLX)

Does Cardlytics, Inc. (CDLX) have what it takes to be a top stock pick for momentum investors? Let's find out.

CDLX : 39.63 (-0.95%)
Cardlytics, Inc. (CDLX) Hits 52-Week High, Can the Run Continue?

Cardlytics, Inc. (CDLX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

CDLX : 39.63 (-0.95%)
TTEC : 43.17 (-5.78%)
SMGZY : 21.0200 (-0.85%)
JT : 2.33 (-3.72%)
S&P Reaches New Record After Trade Ceasefire

S&P Reaches New Record After Trade Ceasefire

TGT : 110.15 (-0.05%)
SYF : 36.83 (-0.30%)
CIEN : 37.77 (+0.85%)
DG : 156.33 (-0.97%)
CLS : 8.07 (+3.07%)
KEYS : 105.55 (+0.29%)
CLR : 31.74 (-3.00%)
BRY : 11.06 (+0.09%)
CDLX : 39.63 (-0.95%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

See More Share

Trade CDLX with:

Business Summary

Cardlytics, Inc. is engaged in developing a purchase intelligence platform. The purchase data includes debit, credit and bill pay data from online and in-store transactions. It helps the marketers identify, reach and influence likely buyers at scale, and measure the impact of marketing spends. The Company...

See More

Key Turning Points

2nd Resistance Point 41.38
1st Resistance Point 40.70
Last Price 39.63
1st Support Level 39.56
2nd Support Level 39.10

See More

52-Week High 42.19
Last Price 39.63
Fibonacci 61.8% 29.82
Fibonacci 50% 25.99
Fibonacci 38.2% 22.17
52-Week Low 9.80

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar